Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Bearish
5
Neutral
5
Bullish
4
Bearish
7
Neutral
5
Bullish
34
Bearish
2
Neutral
0
Bullish
30
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Market Cap
₹ 22 Cr
P/E
48.65
Insider Trading Disclosure
2 days ago
Disclosure of Shares Transmission by Promoter
Submission of disclosure under SEBI PIT Regulation regarding the transmission of shares from late Dr. Mani L.S. to his nominee Mrs. Vijaya Mani.
Regulatory Filing
2 days ago
Transmission of Shares to Ms. Vijaya Mani
Ms. Vijaya Mani receives shareholding from her late husband as part of the regulatory disclosure under SEBI norms.
Regulatory Filing
2 days ago
Disclosure of Share Transmission
The promoter's shareholding of 867,750 equity shares has been transmitted to Mrs. Vijaya Mani following the demise of Dr. Mani L.S., with no change in overall promoter group shareholding.
Pharmaceuticals
Pharmaceuticals - Indian - Formulations
22 Cr
Low Risk
48.7
43.8
3.6
1.9
88.70
36.11
Sales CAGR
1Y
-7.11%
3Y
-2.18%
5Y
-3.00%
10Y
-2.76%
Profit CAGR
1Y
2.04%
3Y
13.54%
5Y
30.65%
10Y
20.23%
ROE
TTM
4.69%
3Y
5.42%
5Y
4.78%
10Y
3.62%
ROCE
TTM
5.88%
3Y
7.36%
5Y
6.77%
10Y
5.12%
Performance
STEADY PERFORMER
Valuation
OVERVALUED
Growth
SLUGGISH
Profitability
MODERATE MARGIN
Technicals
Bullish
Risk
MODERATE RISK
Turned 1 L into 3.34 L in last 5 Years